Bio-Rad Launches InteliQ Diabetes Load-and-Go Quality Control
The InteliQ Diabetes Control includes three distinct levels that may address the HbA1c precision monitoring needs of a wide range of test methods.
Read MorePosted by Melanie Hamilton-Basich | May 20, 2021 | Controls, Diabetes & Metabolic Diseases |
The InteliQ Diabetes Control includes three distinct levels that may address the HbA1c precision monitoring needs of a wide range of test methods.
Read MorePosted by Melanie Hamilton-Basich | May 12, 2021 | Sexually Transmitted Diseases |
The University of Chicago Medicine maintained screening volumes by including universal HIV screening alongside COVID-19 testing in its busy emergency department, according to a new report.
Read MorePosted by Melanie Hamilton-Basich | May 6, 2021 | Diabetes & Metabolic Diseases |
Helen Murray Free, a chemist who co-developed the revolutionary dip-and-read diabetes test that simplified diagnosis and inspired other similar testing, has died.
Read MorePosted by Melanie Hamilton-Basich | May 6, 2021 | Covid 19 |
Urine analysis of COVID-19 patients revealed elevated levels of specific biomarkers of the immune system compared to those who were not infected with the coronavirus.
Read MorePosted by Melanie Hamilton-Basich | May 3, 2021 | Immunoassay |
Roche announced five new intended uses for two key cardiac biomarkers using the Elecsys technology: high sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide test.
Read More